Jubilant Pharmova Limited (NSE: JUBLPHARMA)
India flag India · Delayed Price · Currency is INR
1,097.40
+32.70 (3.07%)
Dec 24, 2024, 3:30 PM IST

Jubilant Pharmova Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2019 - 2015
Market Capitalization
173,68790,43244,41861,740108,37539,635
Upgrade
Market Cap Growth
163.70%103.60%-28.06%-43.03%173.43%-61.69%
Upgrade
Enterprise Value
193,582117,28370,88182,624136,64269,995
Upgrade
Last Close Price
1097.40566.61273.82375.70654.27239.38
Upgrade
PE Ratio
29.28117.29-14.9212.974.41
Upgrade
PS Ratio
2.641.350.711.011.780.66
Upgrade
PB Ratio
3.081.670.821.162.290.71
Upgrade
P/TBV Ratio
7.644.692.202.875.981.42
Upgrade
P/FCF Ratio
-122.87-25.998.624.09
Upgrade
P/OCF Ratio
23.769.316.727.376.072.57
Upgrade
EV/Sales Ratio
2.801.751.131.352.241.17
Upgrade
EV/EBITDA Ratio
18.9114.7810.977.759.314.52
Upgrade
EV/EBIT Ratio
27.6522.4218.919.8411.945.65
Upgrade
EV/FCF Ratio
-70.55159.35-34.7810.877.22
Upgrade
Debt / Equity Ratio
0.520.680.680.600.600.86
Upgrade
Debt / EBITDA Ratio
3.144.315.182.821.933.11
Upgrade
Debt / FCF Ratio
-49.78-13.442.254.96
Upgrade
Asset Turnover
0.590.590.590.650.570.50
Upgrade
Inventory Turnover
1.921.731.541.231.020.87
Upgrade
Quick Ratio
0.981.181.261.341.641.16
Upgrade
Current Ratio
1.802.052.122.202.821.92
Upgrade
Return on Equity (ROE)
10.40%1.34%-1.21%8.21%11.09%13.02%
Upgrade
Return on Assets (ROA)
3.52%2.88%2.22%5.55%6.67%6.45%
Upgrade
Return on Capital (ROIC)
4.54%3.60%2.67%6.53%7.95%7.72%
Upgrade
Earnings Yield
3.40%0.85%-1.37%6.70%7.71%22.66%
Upgrade
FCF Yield
-1.50%0.81%-3.46%3.85%11.60%24.44%
Upgrade
Dividend Yield
0.46%0.88%1.83%1.33%0.76%2.09%
Upgrade
Payout Ratio
13.42%103.50%-19.34%0.18%16.84%
Upgrade
Buyback Yield / Dilution
0.03%0.18%0.02%0.06%0.01%-2.19%
Upgrade
Total Shareholder Return
0.49%1.07%1.84%1.39%0.77%-0.10%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.